{"entity":{"type":"insider","cik":"0001662521","url":"/insider/0001662521","json_url":"/insider/0001662521.json","name":"Connaughton Bernadette","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":9,"first":"2025-09-02","last":"2026-08-11","span_basis":"filed_date"},"name_variants":[{"name":"Connaughton Bernadette","source":"filing","n_filings":9,"first_seen":"2025-09-02","last_seen":"2026-08-11"}],"transactions":[{"id":9294485,"accession":"0001662521-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001662521-26-000002","line_url":"/filing/0001662521-26-000002#line-1","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001662521","owner_name":"Connaughton Bernadette","owner_display_name":"Connaughton Bernadette","owner_url":"/insider/0001662521","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1626.0,"shares_display":"1,626","price_per_share":102.8,"price_display":"102.80","price_state":"stated","total_value":167152.8,"total_display":"167,152.80","total_whole":"167,153","shares_owned_after":40418.0,"shares_owned_after_display":"40,418","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-10","filed_date":"2026-08-11","scope":"insider"},{"id":6193731,"accession":"0001159036-26-000094","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001159036-26-000094","line_url":"/filing/0001159036-26-000094","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001662521","owner_name":"Connaughton Bernadette","owner_display_name":"Connaughton Bernadette","owner_url":"/insider/0001662521","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1625.0,"shares_display":"1,625","price_per_share":76.70807692307692,"price_display":"76.71","price_state":"stated","total_value":124650.625,"total_display":"124,650.62","total_whole":"124,651","shares_owned_after":42669.0,"shares_owned_after_display":"42,669","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-01","filed_date":"2026-07-02","scope":"insider","n_lines":2},{"id":5957609,"accession":"0001159036-26-000072","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001159036-26-000072","line_url":"/filing/0001159036-26-000072#line-1","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001662521","owner_name":"Connaughton Bernadette","owner_display_name":"Connaughton Bernadette","owner_url":"/insider/0001662521","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1625.0,"shares_display":"1,625","price_per_share":66.21,"price_display":"66.21","price_state":"stated","total_value":107591.25,"total_display":"107,591.25","total_whole":"107,591","shares_owned_after":43669.0,"shares_owned_after_display":"43,669","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-01","filed_date":"2026-06-02","scope":"insider"},{"id":6169910,"accession":"0001159036-26-000055","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001159036-26-000055","line_url":"/filing/0001159036-26-000055#line-1","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001662521","owner_name":"Connaughton Bernadette","owner_display_name":"Connaughton Bernadette","owner_url":"/insider/0001662521","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1625.0,"shares_display":"1,625","price_per_share":63.48,"price_display":"63.48","price_state":"stated","total_value":103155.0,"total_display":"103,155.00","total_whole":"103,155","shares_owned_after":38498.0,"shares_owned_after_display":"38,498","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-01","filed_date":"2026-05-05","scope":"insider"},{"id":6000295,"accession":"0001159036-26-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001159036-26-000006","line_url":"/filing/0001159036-26-000006#line-1","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001662521","owner_name":"Connaughton Bernadette","owner_display_name":"Connaughton Bernadette","owner_url":"/insider/0001662521","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":70.25,"price_display":"70.25","price_state":"stated","total_value":140500.0,"total_display":"140,500.00","total_whole":"140,500","shares_owned_after":40123.0,"shares_owned_after_display":"40,123","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-06","scope":"insider"},{"id":4270267,"accession":"0001159036-25-000065","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001159036-25-000065","line_url":"/filing/0001159036-25-000065#line-1","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001662521","owner_name":"Connaughton Bernadette","owner_display_name":"Connaughton Bernadette","owner_url":"/insider/0001662521","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":829.0,"shares_display":"829","price_per_share":71.6,"price_display":"71.60","price_state":"stated","total_value":59356.4,"total_display":"59,356.40","total_whole":"59,356","shares_owned_after":42123.0,"shares_owned_after_display":"42,123","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-01","filed_date":"2025-12-01","scope":"insider"},{"id":4671743,"accession":"0001159036-25-000052","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001159036-25-000052","line_url":"/filing/0001159036-25-000052#line-1","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001662521","owner_name":"Connaughton Bernadette","owner_display_name":"Connaughton Bernadette","owner_url":"/insider/0001662521","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":68.48,"price_display":"68.48","price_state":"stated","total_value":136960.0,"total_display":"136,960.00","total_whole":"136,960","shares_owned_after":42952.0,"shares_owned_after_display":"42,952","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-10","filed_date":"2025-11-12","scope":"insider"},{"id":4678179,"accession":"0001662521-25-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001662521-25-000005","line_url":"/filing/0001662521-25-000005","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001662521","owner_name":"Connaughton Bernadette","owner_display_name":"Connaughton Bernadette","owner_url":"/insider/0001662521","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":75.2405,"price_display":"75.24","price_state":"stated","total_value":150481.0,"total_display":"150,481.00","total_whole":"150,481","shares_owned_after":45452.0,"shares_owned_after_display":"45,452","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-01","filed_date":"2025-10-01","scope":"insider","n_lines":2},{"id":4358994,"accession":"0001415889-25-023470","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-023470","line_url":"/filing/0001415889-25-023470","is_derivative":false,"issuer_cik":"0001159036","issuer_name":"HALOZYME THERAPEUTICS, INC.","issuer_ticker":"HALO","issuer_name_source":null,"issuer_url":"/issuer/0001159036","owner_cik":"0001662521","owner_name":"Connaughton Bernadette","owner_display_name":"Connaughton Bernadette","owner_url":"/insider/0001662521","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":73.68405975,"price_display":"73.68","price_state":"stated","total_value":294736.239,"total_display":"294,736.24","total_whole":"294,736","shares_owned_after":47875.0,"shares_owned_after_display":"47,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-02","filed_date":"2025-09-02","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001159036","name":"HALOZYME THERAPEUTICS, INC.","url":"/issuer/0001159036","role":"Director","n_filings":9,"first_seen":"2025-09-02","last_seen":"2026-08-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001662521","retrieved_at":"2026-08-27T16:04:32+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}